LCT Undertakes $2.5 Million Capital Raise Initiative
Filed with ASX · · 4 pages · English
Algorae Pharmaceuticals Limited on 6ix
Earlier from Algorae Pharmaceuticals
- Half Year Accounts and Appendix 4D
- Trading Halt
- Quarterly Activity Report and Appendix 4C
- New milestone for LCTs AI development
- Preliminary Final Report and 2022 Financial Statements
Later from Algorae Pharmaceuticals
- Pause in Trading
- APeT Cleansing Announcement
- Rights Issue Prospectus
- LCT Announces Shortfall Completion Notice
- Patent application over AI-116 for Dementia filed
Follow Algorae Pharmaceuticals into a list and get an email when it puts out news.
Follow Algorae Pharmaceuticals